R L Cavanagh

447 total citations
14 papers, 335 citations indexed

About

R L Cavanagh is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, R L Cavanagh has authored 14 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Physiology and 3 papers in Organic Chemistry. Recurrent topics in R L Cavanagh's work include Pain Mechanisms and Treatments (3 papers), Gastroesophageal reflux and treatments (2 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). R L Cavanagh is often cited by papers focused on Pain Mechanisms and Treatments (3 papers), Gastroesophageal reflux and treatments (2 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). R L Cavanagh collaborates with scholars based in United States and Germany. R L Cavanagh's co-authors include J P Buyniski, M. E. Bierwagen, Jonas A. Gylys, John E. Starrett, Alfred R. Crosswell, Anthony W. Pircio, John E. Schurig, Leonard S. Gottlieb, Norman Zamcheck and Lawrence E. Roebel and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Alimentary Pharmacology & Therapeutics.

In The Last Decade

R L Cavanagh

13 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R L Cavanagh United States	9	111	94	70	63	57	14	335
Sharon Pan United States	12	66 0.6×	68 0.7×	53 0.8×	23 0.4×	12 0.2×	37	346
G Bruni Italy	9	96 0.9×	73 0.8×	42 0.6×	18 0.3×	5 0.1×	47	313
Long Jp United States	12	173 1.6×	37 0.4×	156 2.2×	48 0.8×	7 0.1×	49	373
Philip I Hair New Zealand	9	132 1.2×	26 0.3×	13 0.2×	58 0.9×	20 0.4×	12	385
R. G. Hill United Kingdom	3	39 0.4×	58 0.6×	67 1.0×	52 0.8×	10 0.2×	6	351
R.G. Van Inwegen United States	10	144 1.3×	41 0.4×	47 0.7×	91 1.4×	3 0.1×	15	366
E. Bojesen Denmark	11	172 1.5×	15 0.2×	38 0.5×	86 1.4×	6 0.1×	20	483
J. Baldauf Germany	11	122 1.1×	26 0.3×	63 0.9×	67 1.1×	4 0.1×	35	293
R. M. Atkinson	9	89 0.8×	22 0.2×	42 0.6×	24 0.4×	3 0.1×	13	332
Bradford N. Craver United States	9	54 0.5×	35 0.4×	54 0.8×	20 0.3×	9 0.2×	20	241

Countries citing papers authored by R L Cavanagh

Since Specialization

Citations

This map shows the geographic impact of R L Cavanagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R L Cavanagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R L Cavanagh more than expected).

Fields of papers citing papers by R L Cavanagh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R L Cavanagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R L Cavanagh. The network helps show where R L Cavanagh may publish in the future.

Co-authorship network of co-authors of R L Cavanagh

This figure shows the co-authorship network connecting the top 25 collaborators of R L Cavanagh. A scholar is included among the top collaborators of R L Cavanagh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R L Cavanagh. R L Cavanagh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Poindexter, Graham S., Michael A. Foley, James E. Macdonald, et al.. (1993). Isosteric replacement in a series of β-substituted monophosphonate calcium antagonists. Bioorganic & Medicinal Chemistry Letters. 3(12). 2817–2820. 1 indexed citations

Poindexter, Graham S., et al.. (1993). Preparation and in vitro biological evaluation of the enantiomers of the diydropyridine BMY 20014, a combination calcium and α1-adrenoreceptor antagonist. Bioorganic & Medicinal Chemistry Letters. 3(4). 561–564. 3 indexed citations

Starrett, John E., et al.. (1989). Synthesis and biological activity of 3-substituted imidazo[1,2-a]pyridines as antiulcer agents. Journal of Medicinal Chemistry. 32(9). 2204–2210. 79 indexed citations

Cavanagh, R L & J P Buyniski. (1989). Effect of BMY‐25368, a potent and long‐acting histamine H₂‐receptor antagonist, on gastric secretion and aspirin‐induced gastric lesions in the dog. Alimentary Pharmacology & Therapeutics. 3(3). 299–313. 10 indexed citations

Cavanagh, R L, J P Buyniski, & Samuel Schwartz. (1987). Prevention of aspirin-induced gastric mucosal injury by histamine H2 receptor antagonists: a crossover endoscopic and intragastric pH study in the dog.. Journal of Pharmacology and Experimental Therapeutics. 243(3). 1179–1184. 6 indexed citations

Cavanagh, R L, et al.. (1983). A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.. Journal of Pharmacology and Experimental Therapeutics. 224(1). 171–179. 35 indexed citations

Roebel, Lawrence E., R L Cavanagh, & J P Buyniski. (1979). Comparative gastrointestinal and biliary tract effects of morphine and butorphanol (Stadol).. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 10(4). 225–38. 11 indexed citations

Schurig, John E., R L Cavanagh, & J P Buyniski. (1978). Effect of butorphanol and morphine on pulmonary mechanics, arterial blood pressure and venous plasma histamine in the anesthetized dog.. PubMed. 233(2). 296–304. 33 indexed citations

Cavanagh, R L, Jonas A. Gylys, & M. E. Bierwagen. (1976). Antitussive properties of butorphanol.. PubMed. 220(2). 258–68. 23 indexed citations

10.

Pircio, Anthony W., Jonas A. Gylys, R L Cavanagh, J P Buyniski, & M. E. Bierwagen. (1976). The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic.. PubMed. 220(2). 231–57. 97 indexed citations

11.

Fleming, John, J P Buyniski, R L Cavanagh, & M. E. Bierwagen. (1975). Pharmacology of a potent, new antithrombotic agent, 6-methyl-1,2,3,5-tetrahydroimidazo[2, 1-b] quinazolin-2-one hydrochloride monohydrate.. Journal of Pharmacology and Experimental Therapeutics. 194(2). 435–449. 14 indexed citations

12.

Cavanagh, R L, et al.. (1974). Possible mechanism for the fibrinolytic effect of certain bis-tetrahydroisoquinolines: Evidence for histamine release. Thrombosis Research. 5(5). 633–645. 1 indexed citations

13.

Cavanagh, R L, et al.. (1959). The effect of aminopterin on the absorption of xylose from the rat small intestine. Digestive Diseases and Sciences. 4(9). 700–705. 21 indexed citations

14.

Cavanagh, R L, et al.. (1959). The influence of concentration on the absorption of sugars from the small intestine of rats. Digestive Diseases and Sciences. 4(9). 706–709. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact